Vaporized Cannabis Shows Migraine Relief in First Placebo-Controlled Human Trial
First rigorous human trial proves vaporized cannabis dramatically outperforms placebo for migraine relief, challenging decades of pharmaceutical-only treatment approaches.
Arizona AG Fights Cash Dependency in Cannabis Banking Reform Campaign
Arizona’s AG exposes how federal banking restrictions force $30 billion cannabis industry into dangerous cash-only operations. Violence and crime follow the money.
New Jersey’s Cannabis Lounges Get First Green Light in 4 Diverse Cities
New Jersey breaks cannabis barriers by approving the first four consumption lounges in unexpected locations. These groundbreaking social spaces challenge everything you know about legal marijuana.
Why California’s Construction Industry Still Drug Tests for Marijuana Despite New Worker Protections
Despite California’s new marijuana protections, construction workers face continued drug testing—even for off-duty use. The controversial exemption creates unexpected legal gaps.
Turkey Embraces Strictly Regulated Medical Cannabis Sales, Pharmacies Now the Exclusive Gatekeepers
Turkey breaks centuries of cannabis prohibition with a shocking pharmacy-only medical cannabis system that excludes recreational use entirely. Will this strict approach actually work?
Controversial Petition Law Could Fast-Track Oklahoma Marijuana Legalization Amid Rising Youth Concerns
Oklahoma’s controversial petition law threatens to derail marijuana legalization as youth usage soars 73% since 2018. Will advocates overcome these mounting obstacles?
Psychedelics and Cannabis Outshine Antidepressants in Eating Disorder Relief, According to New Survey
International survey of 7,600 people reveals cannabis and psychedelics outperform FDA-approved antidepressants for eating disorders. Traditional medicine isn’t working.
